JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB124885

Anti-FLCN antibody [EPNCIR147]

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Recombinant Monoclonal FLCN antibody. Suitable for WB and reacts with Human samples. Cited in 5 publications.

View Alternative Names

BHD, FLCN, Folliculin, BHD skin lesion fibrofolliculoma protein, Birt-Hogg-Dube syndrome protein

3 Images
Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)
  • WB

Unknown

Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)

All lanes:

Western blot - Anti-FLCN antibody [EPNCIR147] (ab124885) at 1/1000 dilution

Lane 1:

293T cell lysate at 10 µg

Lane 2:

NCCIT cell lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 64 kDa

Observed band size: 70 kDa

false

Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)
  • WB

Lab

Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)

Western blot : Anti-FLCN antibody [EPNCIR147] ab124885 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 64 kDa in Wild-type A549 cell lysates with no signal observed at this size in FLCN knockout A549 cell line.

To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 100pc LICOR in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.

Lanes 1 - 3:

Western blot - Anti-FLCN antibody [EPNCIR147] (ab124885) at 1/1000 dilution

Lanes 1 - 3:

Western blot - Anti-FLCN antibody [EPNCIR147] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/flcn-antibody-epncir147-bsa-and-azide-free-ab248039'>ab248039</a>) at 1/1000 dilution

Lane 1:

Wild-type A549 at 20 µg

Lane 2:

FLCN knockout A549 at 20 µg

Lane 3:

HEK-293 at 20 µg

Secondary

All lanes:

Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 64 kDa

Observed band size: 64 kDa

false

Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)
  • WB

Lab

Western blot - Anti-FLCN antibody [EPNCIR147] (AB124885)

Lanes 1 - 4 : Merged signal (red and green). Green - ab124885 observed at 64 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.

ab124885 was shown to react with FLCN in wild-type HeLa cells in Western blot with loss of signal observed in FLCN knockout cell line ab265268 (FLCN knockout cell lysate ab257953). Wild-type HeLa and FLCN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab124885 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-FLCN antibody [EPNCIR147] (ab124885) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

FLCN knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human FLCN knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-flcn-knockout-hela-cell-line-ab265268'>ab265268</a>)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

HEK-293 cell lysate at 20 µg

Predicted band size: 64 kDa

Observed band size: 64 kDa

false

  • Carrier free

    Anti-FLCN antibody [EPNCIR147] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPNCIR147

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

This antibody was developed as part of a collaboration between the National Cancer Institute's Center for Cancer Research and the lab of Marston Linehan. View antibodies from NCI Center for Cancer Research Collaboration.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Folliculin (FLCN) protein also known by its gene name BHD serves as a tumor suppressor and has significant roles in cellular processes. FLCN comprises 579 amino acids resulting in a molecular weight of approximately 64 kDa. It expresses in various tissues notably in the skin kidney and lung. FLCN interacts with several proteins and serves essential roles in maintaining cell stability.
Biological function summary

FLCN plays a role in energy and nutrient sensing within cells. It forms part of a complex with FNIP1 and FNIP2 proteins which helps regulate cellular growth and metabolism. This complex acts as a hub for integrating various signaling pathways influencing how cells respond to changing metabolic states.

Pathways

Research connects FLCN to the mTOR signaling pathway and AMP-activated protein kinase (AMPK) pathway which are critical for cellular metabolism and energy homeostasis. The interaction between FLCN and the mTOR pathway facilitates control over cell growth and proliferation by sensing cellular energy levels. Moreover FLCN associates with pathways that include proteins like TSC1 and TSC2 which also contribute to the regulation of these pathways.

FLCN mutations link to Birt-Hogg-Dubé syndrome a genetic disorder causing skin lung and kidney anomalies. Its dysfunction also associates with certain types of kidney cancer where FLCN's tumor suppressor role becomes evident. Altered interactions between FLCN and other proteins such as AMPK can contribute to disease progression highlighting FLCN's importance in medical research concerning cancer and genetic disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Multi-functional protein, involved in both the cellular response to amino acid availability and in the regulation of glycolysis (PubMed : 17028174, PubMed : 18663353, PubMed : 21209915, PubMed : 24081491, PubMed : 24095279, PubMed : 31672913, PubMed : 31704029, PubMed : 32612235, PubMed : 34381247, PubMed : 36103527, PubMed : 37079666). GTPase-activating protein that plays a key role in the cellular response to amino acid availability through regulation of the non-canonical mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3 (PubMed : 17028174, PubMed : 18663353, PubMed : 21209915, PubMed : 24081491, PubMed : 24095279, PubMed : 24448649, PubMed : 31672913, PubMed : 31704029, PubMed : 32612235, PubMed : 36103527, PubMed : 37079666). Activates mTORC1 by acting as a GTPase-activating protein : specifically stimulates GTP hydrolysis by RagC/RRAGC or RagD/RRAGD, promoting the conversion to the GDP-bound state of RagC/RRAGC or RagD/RRAGD, and thereby activating the kinase activity of mTORC1 (PubMed : 24095279, PubMed : 31672913, PubMed : 31704029, PubMed : 32612235, PubMed : 37079666). The GTPase-activating activity is inhibited during starvation and activated in presence of nutrients (PubMed : 31672913, PubMed : 32612235). Acts as a key component for non-canonical mTORC1-dependent control of the MiT/TFE factors TFEB and TFE3, while it is not involved in mTORC1-dependent phosphorylation of canonical RPS6KB1/S6K1 and EIF4EBP1/4E-BP1 (PubMed : 21209915, PubMed : 24081491, PubMed : 31672913, PubMed : 32612235). In low-amino acid conditions, the lysosomal folliculin complex (LFC) is formed on the membrane of lysosomes, which inhibits the GTPase-activating activity of FLCN, inactivates mTORC1 and maximizes nuclear translocation of TFEB and TFE3 (PubMed : 31672913). Upon amino acid restimulation, RagA/RRAGA (or RagB/RRAGB) nucleotide exchange promotes disassembly of the LFC complex and liberates the GTPase-activating activity of FLCN, leading to activation of mTORC1 and subsequent cytoplasmic retention of TFEB and TFE3 (PubMed : 31672913). Indirectly acts as a positive regulator of Wnt signaling by promoting mTOR-dependent cytoplasmic retention of MiT/TFE factor TFE3 (PubMed : 31272105). Required for the exit of hematopoietic stem cell from pluripotency by promoting mTOR-dependent cytoplasmic retention of TFE3, thereby increasing Wnt signaling (PubMed : 30733432). Acts as an inhibitor of browning of adipose tissue by regulating mTOR-dependent cytoplasmic retention of TFE3 (By similarity). Involved in the control of embryonic stem cells differentiation; together with LAMTOR1 it is necessary to recruit and activate RagC/RRAGC and RagD/RRAGD at the lysosomes, and to induce exit of embryonic stem cells from pluripotency via non-canonical, mTOR-independent TFE3 inactivation (By similarity). In response to flow stress, regulates STK11/LKB1 accumulation and mTORC1 activation through primary cilia : may act by recruiting STK11/LKB1 to primary cilia for activation of AMPK resided at basal bodies, causing mTORC1 down-regulation (PubMed : 27072130). Together with FNIP1 and/or FNIP2, regulates autophagy : following phosphorylation by ULK1, interacts with GABARAP and promotes autophagy (PubMed : 25126726). Required for starvation-induced perinuclear clustering of lysosomes by promoting association of RILP with its effector RAB34 (PubMed : 27113757). Regulates glycolysis by binding to lactate dehydrogenase LDHA, acting as an uncompetitive inhibitor (PubMed : 34381247).
See full target information FLCN

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Nature 620:200-208 PubMed37407815

2023

SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Chuansheng Guo,Zhiyuan You,Hao Shi,Yu Sun,Xingrong Du,Gustavo Palacios,Cliff Guy,Sujing Yuan,Nicole M Chapman,Seon Ah Lim,Xiang Sun,Jordy Saravia,Sherri Rankin,Yogesh Dhungana,Hongbo Chi

PLoS biology 20:e3001594 PubMed35358174

2022

Folliculin promotes substrate-selective mTORC1 activity by activating RagC to recruit TFE3.

Applications

Unspecified application

Species

Unspecified reactive species

Kristina Li,Shogo Wada,Bridget S Gosis,Chelsea Thorsheim,Paige Loose,Zolt Arany

Human molecular genetics 28:3270-3281 PubMed31272105

2019

Loss of FLCN inhibits canonical WNT signaling via TFE3.

Applications

Unspecified application

Species

Unspecified reactive species

John C Kennedy,Damir Khabibullin,Thomas Hougard,Julie Nijmeh,Wei Shi,Elizabeth P Henske

JCI insight 5: PubMed30843872

2019

Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Li,Shogo Wada,Lehn K Weaver,Chhanda Biswas,Edward M Behrens,Zoltan Arany

Genes & development 30:2551-2564 PubMed27913603

2016

The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.

Applications

Unspecified application

Species

Unspecified reactive species

Shogo Wada,Michael Neinast,Cholsoon Jang,Yasir H Ibrahim,Gina Lee,Apoorva Babu,Jian Li,Atsushi Hoshino,Glenn C Rowe,James Rhee,José A Martina,Rosa Puertollano,John Blenis,Michael Morley,Joseph A Baur,Patrick Seale,Zoltan Arany
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com